Shares of Amprius Technologies surged 5.7% to $21.44 on June 1, extending a blistering rally that has taken the stock from $16.03 just a week ago — a 34% gain in five trading days. The catalyst: a packed June events schedule layered on top of a bullish industry report valuing the silicon anode battery market at over $31 billion by 2035. For shareholders, the question is whether investor-relations hustle can substitute for the profits Amprius still doesn't have.
A Busy June Keeps Amprius in Front of Wall Street
The company's CFO will present and hold one-on-one investor meetings at the William Blair Growth Conference on June 3.
The CEO and CFO will jointly appear at the Jefferies Innovative Aerospace Virtual Summit on June 8.
Amprius will also exhibit at Eurosatory, the major defense expo in Paris, June 15–19 , and at the Automate robotics show in Chicago, June 22–25. Four high-profile touchpoints in a single month keep the narrative alive — critical for a stock that trades on story as much as on spreadsheets.
Revenue Is Real, but the Losses Haven't Disappeared
Q1 2026 revenue hit $28.5 million, up over 2.5x year-over-year , and the company raised its full-year outlook to at least $130 million, targeting net loss below $8 million and positive adjusted EBITDA of at least $4 million. Yet at roughly 141.6 million shares outstanding and today's price, the implied market cap approaches $3 billion — roughly 29x trailing sales . That prices in years of flawless execution.
A Booming Market Doesn't Mean Amprius Wins It
The global silicon anode battery market was valued at $536.6 million in 2025 and is projected to reach $31.27 billion by 2035, growing at a roughly 50% annual clip.
U.S. growth is fueled by federal investment and competition from Group14 Technologies, Sila Nanotechnologies, and Enovix. Amprius has a head start in drones and aviation, but rivals are scaling fast.
Cash Burn Is the Real Clock Ticking
Amprius ended Q1 with $62.4 million in cash, down from $90.5 million at year-end 2025 — a $28 million quarterly draw. Full-year capital spending is guided below $10 million , so the burn is mostly operational. If EBITDA turns positive as guided, the runway stretches. If not, another capital raise looms for a company that recently issued 2.7 million shares to retire warrants in May.
Bottom line: The conference tour keeps Amprius visible, and the market it's chasing is enormous. But at 29x sales and cash still draining, the stock is priced for perfection in an industry where manufacturing scale — not slide decks — ultimately wins.